Researchers suggest appropriate monitoring and use of standard treatment algorithms to identify and treat toxic effects after a rechallenge after irAEs in patients receiving ICI therapy.
One percent of participants underwent PET-CT imaging due to false-positive blood tests.
The FDA has approved the supplemental Biologics License Application (sBLA) for Keytruda® (Merck) to include an additional recommended dosage of 400mg every 6 weeks across all adult indications.
Image-guided percutaneous cryoablation is a safe and efficacious treatment for selected small renal cell carcinoma (RRC) tumors, new findings published in the American Journal of Roentgenology confirm. Joint first authors Emma Lim, MBChB, and Shankar Kumar, MBBS, senior author and attending interventional radiologist Miles Walkden, FRCR, and others at University College London Hospitals NHS Foundation…
Age and gender do not impact overall survival (OS) among patients who receive targeted therapy for metastatic renal cell carcinoma (mRCC), according to a new study. Younger patients, however, have shorter progression-free survival (PFS), and elderly patients experience more adverse events, investigators reported in a paper published online in Clinical Genitourinary Cancer. “These findings are…
In a study of SEER registry patients with renal cell carcinoma, variant histology subtypes were associated with higher cancer-specific mortality than grade 4 clear-cell carcinoma.
Patients who received off-label adjuvant targeted therapy after nephrectomy for locoregional renal cell carcinoma had shorter median survival times than those who did not, a study found.
Larger tumors and younger age are significantly associated with an increased risk of brain metastasis in patients with renal cell carcinoma, according to investigators.
AKI promotes the development of papillary renal cell carcinoma from single progenitors.
In a study, patients with kidney failure due to urinary tract cancers had an increased mortality risk and decreased access to kidney transplantation if they had active malignancy at the start of dialysis.
